Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Antibodies

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) Antibody

Product Sizes
20 ug
£364.00
29126-MSM4-P0-20UG
About this Product
SKU:
29126-MSM4-P0
Additional Names:
B7 homolog 1
Application:
ELISA, Western Blot
translate.label.attr.clone:
PDL1/2744
Clonality:
Monoclonal
Extra Details:
Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T-cell proliferation; cytokine production; differentiation of effector T-cells and the induction of BCLX; a promoter of T-cell survival. Engagement of CTLA4 by B7-1 or B7-2; on the other hand; may inhibit proliferation and interleukin-2 (IL-2) production. PD-L1 is 290-amino acid type I transmembrane protein; which is 20% and 15% identical to B7-1 and B7-2; respectively; has immunoglobulin V-like and C-like domains and a 30-amino acid cytoplasmic tail. PD-L1 does not bind CD28; cytotoxic T-lymphocyte A4 or ICOS (inducible co-stimulator). IL-2; although produced in small amounts; is required for the effect of PD-L1 co-stimulation. PD-L2 protein contains a signal sequence; IgV- and IgC-like domains; a transmembrane region and a cytoplasmic region. The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart; lung and kidney suggests that the PD-1-PD-L system could provide unique negative signaling to help prevent autoimmune diseases.
Host:
Mouse
Immunogen:
Recombinant fragment of human CD274 protein (around aa39-191) (exact sequence is proprietary)
Isotype:
IgG1
Molecular Weight:
37-50kDa
Research Area:
Immunology; Mast Cell Marker; PD-1 blockade immunotherapy; Signal Transduction
Shipping Conditions:
Blue Ice
Storage Conditions:
Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
Supplier:
NeoBiotechnologies
Type:
Antibodies: Monoclonal Antibody